August 2026 Edition
About the Newsletter
Each edition draws from RegulatoryID, MedPro's expert-maintained reference covering transparency and compliance requirements across 50+ countries. The team that maintains the compendium also curates each newsletter, surfacing the deadlines, filings and rule changes most relevant to Life Sciences manufacturers, distributors and medical device companies in the month ahead.
What You Receive Each Month
A single monthly newsletter delivered the first Tuesday of each month, covering U.S. and international jurisdictions
Concise high-level summaries in the email so you can quickly scan deadlines and what's required
Linked detailed summaries with full regulatory context, deadlines and reference links
Immediate alerts for urgent developments that cannot wait for the next monthly send
Inside the August Edition
This month's update covers one upcoming September international disclosure deadline.
Subscribe to access the full requirements, source links, and submission details.
France Semiannual Disclosure Due 9/1
Semiannual disclosure under the French Sunshine Act is due September 1 to the French Ministry of Health and Access to Healthcare. The French Sunshine Act requires pharmaceutical and medical device companies, both French and foreign, to semiannually report the benefits granted to reportable beneficiaries who practice or are located in France.
Subscribe to the RegulatoryID Newsletter
Enter your work email to request access to the full August 2026 edition and to receive ongoing updates direct to your inbox.